Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia.


Journal

International journal of pharmaceutical compounding
ISSN: 1092-4221
Titre abrégé: Int J Pharm Compd
Pays: United States
ID NLM: 9706294

Informations de publication

Date de publication:
Historique:
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 25 6 2020
Statut: ppublish

Résumé

Intrathecal analgesia is a method using various molecules alone or in combination. Among these, a preparation of sufentanil-ropivacaine-baclofen is widely used. Instead of moving patients to the few expert centers taking charge of these specific preparations, it could be beneficial to transport syringes to peripheral centers who manage pump refills. The objective of this study was to determine the physicochemical compatibility and stability of a preparation of sufentanil, ropivacaine, and baclofen in polypropylene syringes. Drugs were mixed together at different concentrations and stored with light protection at 5°C ± 3°C and 25°C ± 2°C. The stabilities were determined by visual inspection, turbidity, pH measurement, and ultra-high-pressure liquid chromatography assay of drug concentrations. The concentrations of ropivacaine, baclofen, and sufentanil were stable after 7 days at 5°C ± 3°C and no degradation of product appeared. The drug mixtures were clear in appearance and no color change or precipitation was observed. Throughout this period, the absorbance and the pH value of samples remained stable. The preparations of sufentanil, baclofen, and ropivacaine remained stable for at least 7 days when stored in polypropylene syringes at 5°C ± 3°C.

Identifiants

pubmed: 32196478

Substances chimiques

Polypropylenes 0
Ropivacaine 7IO5LYA57N
Sufentanil AFE2YW0IIZ
Baclofen H789N3FKE8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-162

Informations de copyright

Copyright© by International Journal of Pharmaceutical Compounding, Inc.

Auteurs

Jérémy Sorrieul (J)

Pharmacy Department, Institut de Cancérologie de l'Ouest Paul Papin, Angers, France. jeremy.sorrieul@ico.unicancer.fr.

Julien Robert (J)

Pharmacy Department, Institut de Cancérologie de l'Ouest Paul Papin, Angers, France.

Fanny Chapel (F)

Pharmacy Department, Institut de Cancérologie de l'Ouest Paul Papin, Angers, France.

Thomas Gossye (T)

Pharmacy Department, Institut de Cancérologie de l'Ouest Paul Papin, Angers, France.

Catherine Devys (C)

Pharmacy Department, Institut de Cancérologie de l'Ouest Paul Papin, Angers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH